Administration of ADAKVEO® follows a 5 mg/kg by intravenous infusion over a period of 30 minutes on Week 0, Week 2, and every 4 weeks thereafter.
Most common adverse reactions (incidence > 10%) are nausea, arthralgia, back pain, abdominal pain, and pyrexia.
Please see full Prescribing Information including Patient Information.
|
Privacy Policy | © 2024 Vital Care of Tulsa